Showing Results for: “how medications like Tirzepatide work”

American Diabetes Association Symposium Demonstrates Benefits of Once Weekly Drug for Weight Loss and Glycemic Control Today, findings from SURMOUNT-2, a study of tirzepatide in participants with type 2 diabetes who have obesity were announced, demonstrating more weight loss in individuals with diabetes than any other medication to date. The results were presented at the 83rd Scientific Sessions of the American Diabetes Association ® (ADA) in San Diego, CA and were simultaneously published in The Lancet. Obesity impacts 650 million people worldwide including nearly half of all Americans and is

Learn about the different classes of non-insulin type 2 diabetes medications used to lower blood glucose levels. Explore options like Metformin, DPP-4 inhibitors, GLP-1, and more.